Japan Agency for Medical Research and Development (AMED) leads the Initiative on Rare and Undiagnosed Diseases (IRUD) program. The program provides patients across Japan suffering from undiagnosed diseases with a diagnostic strategy that involves genetic analysis
View this resource Bookmark this resource
AMED Clinical Innovation network – Diseases-related Registries
Published by IRDiRC
Agency For Medical Research and DevelopmentCinical TrialClinical DevelopmentClinical Innovation NetworkInitiative on Rare DiseasesJapanPatient RegistryResearch and Drug Development
